Infacare Pharmaceutical
Trevose, US · Delaware corporation
Founders & leadership
RG
Ron GoldfussExecutive
DB
Dan BurnsExecutive
RV
Robert VukovichNamed on SEC filing
Board
PE
Patrick EnrightBoard director
PB
Peter BarrettBoard director
HW
Harold WernerBoard director
WC
William CrouseBoard director
RV
Richard VietorBoard director
Reported raises · per SEC filings
Form D private placements$23.1M disclosed across 5 rounds · 2014–2017
▶$3.5MraisedJun 2017 · 11 investors · PharmaceuticalsRule 506(b)
▶$3.5MraisedJun 2017 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert VukovichDirector
- Harold WernerDirector
- Peter BarrettDirector
- Patrick EnrightDirector
- William CrouseDirector
- E. Ronald GoldfussExecutive Officer
- Dan BurnsExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $3.5M
- Proceeds to insiders
- $293K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedNov 2016 · 11 investors · PharmaceuticalsRule 506(b)
▶$5.5MraisedNov 2016 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dan BurnsExecutive Officer, Director
- Peter BarrettDirector
- Patrick EnrightDirector
- Harold WernerDirector
- William CrouseDirector
- Robert VukovichDirector
- Ron GoldfussExecutive Officer
- Offering amount
- $11M
- Amount sold
- $5.5M
- Proceeds to insiders
- $350K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.1MraisedJul 2015 · 10 investors · PharmaceuticalsRule 506(b)
▶$12.1MraisedJul 2015 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Patrick EnrightDirector
- Robert VukovichDirector
- Ron GoldfussExecutive Officer
- Peter BarrettDirector
- Dan BurnsExecutive Officer, Director
- Harold WernerDirector
- William CrouseDirector
- Offering amount
- $12.1M
- Amount sold
- $12.1M
- Proceeds to insiders
- $600K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedDec 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedDec 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert VukovichDirector
- Peter BarrettDirector
- Ron GoldfussExecutive Officer
- Dan BurnsExecutive Officer, Director
- Richard VietorDirector
- Patrick EnrightDirector
- Harold WernerDirector
- William CrouseDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Proceeds to insiders
- $100K
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedOct 2014 · 6 investors · PharmaceuticalsRule 506(b)
▶$750KraisedOct 2014 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William CrouseDirector
- Patrick EnrightDirector
- Robert VukovichDirector
- Harold WernerDirector
- Richard VietorDirector
- Ron GoldfussExecutive Officer
- Peter BarrettDirector
- Dan BurnsExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $750K
- Proceeds to insiders
- $48K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Infacare Pharmaceutical raised?
- Infacare Pharmaceutical has disclosed $23.1M raised across 5 rounds.
- Where is Infacare Pharmaceutical headquartered?
- Infacare Pharmaceutical is headquartered in Trevose, US.